Earlier this year, Leigh Anderson made a compelling argument in a Genome Technology cover story on biomarkers that without the validation step, biomarker discovery on its own doesn't mean a whole lot. "You could say that a biomarker candidate is discovered with proteomics," Anderson told us at the time, "but it’s possible to say that it’s really not a biomarker until you validate it. So, in a peculiar sense, the discovery actually occurs at the stage of validation."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.